Differentiation of bone marrow mesenchymal stem cells modulated by Bushen Tian Sui decoction via the TGF-β1-Smad2/3 signaling pathway: In vitro evidence and potential clinical application in delayed fracture healing
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Wei Xiong und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Transforming Growth Factor beta1, Smad3 Protein, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Xiong, W., Li, B., Chen, J., Shao, Z., Sun, W. K., Li, S., Lu, H., & Cheng, L. (2025). Differentiation of bone marrow mesenchymal stem cells modulated by Bushen Tian Sui decoction via the TGF-β1-Smad2/3 signaling pathway: In vitro evidence and potential clinical application in delayed fracture healing. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204746
Vancouver
Xiong W, Li B, Chen J, Shao Z, Sun WK, Li S, et al. Differentiation of bone marrow mesenchymal stem cells modulated by Bushen Tian Sui decoction via the TGF-β1-Smad2/3 signaling pathway: In vitro evidence and potential clinical application in delayed fracture healing. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204746
BibTeX
@article{Xiong2025,
author = {Xiong, Wei and Li, Bingru and Chen, Jiamin and Shao, Zichen and Sun, Wei-Kang and Li, Song and Lu, Hualong and Cheng, Ling},
title = {Differentiation of bone marrow mesenchymal stem cells modulated by Bushen Tian Sui decoction via the TGF-β1-Smad2/3 signaling pathway: In vitro evidence and potential clinical application in delayed fracture healing},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204746}
}
EUVIMED